Preservation Method Segment Analysis: Static Cold Storage (SCS) (Largest Segment) vs Normothermic Machine Perfusion (NMP) (Fastest-Growing Segment)

Static cold storage (SCS) segment accounted for a 47.17% share of the kidney transplant market in 2026, supported by its established role in organ preservation and its comparatively straightforward operational requirements. The method enables kidneys to be preserved under controlled cold conditions during the period between organ procurement and transplantation, making it a widely used approach across transplant workflows. Its established clinical familiarity, accessibility, and integration into conventional organ transportation practices contribute to continued utilization. Healthcare providers also benefit from established protocols and infrastructure surrounding cold-storage preservation, reinforcing its position in the market.

Normothermic machine perfusion (NMP) is projected to be the fastest-growing preservation method as transplant centers increasingly seek technologies capable of maintaining organs under more physiologically relevant conditions during preservation. NMP can facilitate continuous perfusion and monitoring, creating opportunities to assess organ function and condition before transplantation. This capability is particularly valuable as healthcare systems seek to improve organ utilization and make informed decisions regarding potentially transplantable kidneys. Growing interest in advanced preservation technologies, real-time assessment, and improved transplant outcomes is supporting increasing adoption of machine perfusion approaches.

Transplant Type Segment Analysis: Deceased Donor Transplants (Largest Segment) vs Living Donor Transplants (Fastest-Growing Segment)

Deceased donor transplants segment led the kidney transplant market, accounting for a 70.46% share in 2026. Its dominant position reflects the important role of deceased donor organs in meeting the substantial need for kidney replacement therapy. Established organ donation and allocation systems enable kidneys recovered from deceased donors to be matched with suitable recipients, making this pathway a critical component of transplant programs. Continued efforts to improve organ recovery, preservation, allocation, and utilization are supporting the availability and clinical integration of deceased donor kidneys.

Living donor transplants are expected to be the fastest-growing transplant type as healthcare systems and patients increasingly recognize the advantages associated with planned living donation. Living donor procedures can provide greater flexibility in transplant scheduling and may allow clinical teams to coordinate donor and recipient evaluation more effectively. Growing awareness of living donation, improved donor evaluation processes, and advances in transplant surgery and postoperative care are supporting greater consideration of this pathway. The focus on expanding access to suitable donor organs and improving transplant opportunities is further encouraging the development of living donor programs.